Patent · US Active

Tissue engineered blood vessels

US8491457B2 · kind B2 · utility

26Cited by
16References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 10, 2006
Grant dateJul 23, 2013
Priority date
Expiry dateJul 26, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2430/36
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is directed to methods for preparing artificial blood vessels by preconditioning a matrix seeded with endothelial cells to fluid flow conditions that mimic blood flow.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.